Opendata, web and dolomites

OXIGENATED SIGNED

Hemoglobin based Protein Nanocarriers for Tumour Oxygenation and a more effective Photodynamic Therapy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 OXIGENATED project word cloud

Explore the words cloud of the OXIGENATED project. It provides you a very rough idea of what is the project "OXIGENATED" about.

cancer    hypoxia    skin    oxigenated    oxygen    single    drawback    self    photosensitizer    complexed    photodynamic    thailand    fate    bovine    skills    efficient    spain    simultaneous    actively    surface    limited    breast    estonia    material    treatment    serum    germany    biology    peptides    hemoglobin    stage    emission    models    sme    participation    therapy    multidisciplinary    photosensitizing    generate    malignant    precipitation    co    exposed    carbonates    ultimately    assembly    entrapped    nano    imaging    coating    efficiency    radical    transport    hobcs    training    intracellular    tested    physics    ros    generation    vitro    mice    scientific    core    scientists    molecules    nanocarriers    cells    secondments    toxicity    team    molecular    exchanging    commercialization    tissue    seconded    computer    albumin    therapies    delivered    modified    complementary    death    drug    carriers    environments    science    species    argentina    brazil    homing    forefront    prepared    molecule    chemistry    positron    vivo    tumour    tomography    content    causing    networking    radiolabeled    pdt    gathered    submicron    fundamental   

Project "OXIGENATED" data sheet

The following table provides information about the project.

Coordinator
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE 

Organization address
address: PASEO MIRAMON 182, PARQUE TECNOLOGICO DE SAN SEBASTIAN EDIFICIO EMPRESARIAL C
city: SAN SEBASTIAN
postcode: 20009
website: www.cicbiomagune.es

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 920˙000 €
 EC max contribution 920˙000 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2018
 Funding Scheme MSCA-RISE
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2023-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE ES (SAN SEBASTIAN) coordinator 529˙000.00
2    CHARITE - UNIVERSITAETSMEDIZIN BERLIN DE (BERLIN) participant 211˙600.00
3    TARTU ULIKOOL EE (TARTU) participant 156˙400.00
4    Surflay Nanotec GmbH DE (BERLIN) participant 23˙000.00
5    CHULALONGKORN UNIVERSITY TH (BANGKOK) partner 0.00
6    FUNDACAO UNIVERSIDADE DE BRASILIA BR (BRASILIA DF) partner 0.00
7    UNIVERSIDAD NACIONAL DE GENERAL SAN MARTIN AR (SAN MARTIN BUENOS AIRES) partner 0.00
8    UNIVERSIDAD NACIONAL DEL SUR AR (BAHIA BLANCA) partner 0.00

Map

 Project objective

A major drawback of Photodynamic Therapy (PDT) and other therapies for cancer treatment is the limited oxygen content, hypoxia, in tumour tissue. In PDT a photosensitizing molecule is delivered to malignant tissue to generate radical oxygen species (ROS). The presence of oxygen is fundamental for ROS generation, ultimately causing the death of tumour cells. This project aims to develop hemoglobin drug delivery nanocarriers in the nano and submicron range for simultaneous oxygen and photosensitizer delivery to tumour tissue for a more efficient Photodynamic Therapy. Hemoglobin-based nanocarriers (HOBCs) will be prepared by co-precipitation of hemoglobin with carbonates and surface coating with bovine serum albumin. The carriers will transport oxygen complexed to hemoglobin while photosensitizer molecules will be entrapped in the core. Carriers will be modified with homing peptides to target them to cancer cells. In vitro studies will be conducted to study the uptake of HOBCs by cells, their intracellular fate, toxicity, and oxygen and photosensitizer delivery. In vivo fate of carriers will be studied in mice with radiolabeled carriers by Positron Emission Tomography and Single Emission Computer Tomography. The efficiency of the HOBCs for oxygen delivery and for PDT will be tested in vitro and in vivo in breast and skin cancer models. A multidisciplinary team has been gathered with scientists at the forefront of Material Science, Self assembly, Physics, Chemistry, Imaging, Molecular Biology and Cancer Therapy from Germany, Estonia, Spain, Brazil, Argentina and Thailand. The participation of a SME will be fundamental for the future commercialization of project developments. OXIGENATED will actively work towards exchanging skills and knowledge through secondments of Early Stage and Experienced Researchers, and through networking and training activities. Seconded researchers will develop new scientific and complementary skills while exposed to new research environments.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OXIGENATED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OXIGENATED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

ENDORSE (2018)

Safe, Efficient and Integrated Indoor Robotic Fleet for Logistic Applications in Healthcare and Commercial Spaces

Read More  

TREND (2019)

Transition with Resilience for Evolutionary Development

Read More  

VIDEC (2020)

Visualizing Death Inducing Protein Complexes

Read More